¼¼°èÀÇ Á¤Çü¿Ü°ú¿ë Àç»ýÀÇ·á Á¦Ç° ½ÃÀå ±Ô¸ð, Á¡À¯À², »ê¾÷ µ¿Ç⠺м® ¸®Æ÷Æ® : ÃÖÁ¾ ¿ëµµº°, ¿ëµµº°, Á¦Ç°º°, Áö¿ªº° Àü¸Á°ú ¿¹Ãø(2023-2030³â)
Global Orthopedic Regenerative Surgical Products Market Size, Share & Industry Trends Analysis Report By End-Use (Hospitals, Ambulatory Surgical Centers and Others), By Application, By Product, By Regional Outlook and Forecast, 2023 - 2030
»óǰÄÚµå : 1353404
¸®¼­Ä¡»ç : KBV Research
¹ßÇàÀÏ : 2023³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 309 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,600 £Ü 5,208,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,320 £Ü 6,250,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,048 £Ü 8,750,000
PDF (Corporate User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Á¤Çü¿Ü°ú¿ë Àç»ýÀÇ·á Á¦Ç° ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 54¾ï ´Þ·¯¿¡ ´ÞÇϸç, ¿¹Ãø ±â°£ Áß CAGRÀº 4.2%ÀÇ ½ÃÀå ¼ºÀå·ü·Î »ó½ÂÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

±×·¯³ª ¸ÞµðÄɾ¸ÞµðÄÉÀÌµå ¼­ºñ½º ¼¾ÅÍ(CMS)´Â ÁöºÒ ÀÏÁ¤À» ¼ö¸³ÇÏ°í ¾î¶² ¼ö¼ú°ú ±â¼ú¿¡ ´ëÇØ ÁöºÒÇÒ °¡Ä¡°¡ ÀÖ´ÂÁö¸¦ °áÁ¤ÇÕ´Ï´Ù. ÃÖ±Ù CMSÀÇ »óȯÀ² ÀÎÇÏ·Î º´¿ø°ú ¼ö¼ú¼¾ÅÍ¿¡ ¼ö½Ê¾ï ´Þ·¯ÀÇ ¼ÕÇØ¸¦ ÀÔÈú ¼ö ÀÖÀ¸¸ç, Comprehensive Care for Joint Replacement ¸ðµ¨Àº CMS°¡ 2016³â¿¡ µµÀÔÇÑ »õ·Î¿î °¡Ä¡ ±â¹Ý ÁöºÒ Á¦µµÀÔ´Ï´Ù. Á¤Çü¿Ü°ú¿ë Àç»ýÀÇ·á Á¦Ç°¿¡ ´ëÇÑ ÁöºÒ Á¤Ã¥ÀÌ ºÒÃæºÐÇϰųª ºÒºÐ¸íÇÏ´Ù¸é ÀÇ·á Àü¹®°¡¿Í ȯÀÚµéÀº ÀÌ·¯ÇÑ Ä¡·á¹ýÀ» »ç¿ëÇÏ´Â °ÍÀ» ²¨·ÁÇÒ ¼ö ÀÖ½À´Ï´Ù. »óȯ ¹®Á¦·Î ÀÎÇÑ °æÁ¦Àû Àå¾Ö´Â ȯÀÚ°¡ ÀÌ·¯ÇÑ Ä¡·á¹ýÀ» ÀÌ¿ëÇÏ´Â °ÍÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌó·³ »óȯ Á¤Ã¥ÀÇ Á¦°ø°ú ÀÌ¿ëÀÇ ¾î·Á¿òÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

¶ÇÇÑ COVID-19 ÆÒµ¥¹ÍÀº ¸ÅÃâ ¹× ¼ö¿ä °¨¼Ò, ÀÓ»ó ¿¬±¸ Áß´Ü, ¼±ÅÃÀû Ä¡·á ¿¬±â µîÀÇ °á°ú·Î ½ÃÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. °ø±Þ¸Á Áß´Ü, ¿©Çà Á¦ÇÑ, ±â¾÷ Æó¼â, Á÷¿ø ¹ßº´ ¹× °Ý¸®, »çȸÀû °Å¸®µÎ±â Á¤Ã¥ µîÀ¸·Î ÀÎÇØ Á¶Á÷Àº Ãß°¡ÀûÀÎ ¾÷¹« Àå¾Ö¸¦ °æÇèÇß½À´Ï´Ù. ±³Â÷ ¿À¿°ÀÇ À§ÇèÀ» ÁÙÀ̰í Äڷγª ¹ÙÀÌ·¯½º¿¡ °¨¿°µÈ ȯÀÚ¸¦ Ä¡·áÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» Çâ»ó½Ã۱â À§ÇØ ¼¼°è »ó´ç¼öÀÇ ÀÇ·á ½Ã¼³¿¡¼­ ¿¹Á¤µÈ ¼±ÅÃÀû ¼ö¼úÀ» Áß´ÜÇϰųª ¿¬±âÇß½À´Ï´Ù. ±×·¯³ª ÇâÈÄ ¼ö³â°£ ¼±ÅÃÀû ¼ö¼úÀÇ Àç°³·Î ÀÎÇØ ½ÃÀåÀÌ ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÃÖÁ¾ ¿ëµµ Àü¸Á

ÃÖÁ¾ ¿ëµµ¿¡ µû¶ó ½ÃÀåÀº º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) ¹× ±âŸ·Î ºÐ·ùµË´Ï´Ù. º´¿ø ºÎ¹®Àº 2022³â ½ÃÀå¿¡¼­ °¡Àå ³ôÀº ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. º´¿øÀº ÇコÄÉ¾î »ç¾÷ÀÇ ÁÖ¿ä ¼öÀÔ¿øÀÌÀÚ ±â¼ú Çõ½Å°ú ¿¬±¸¸¦ ÃËÁøÇÏ´Â Áß¿äÇÑ ¿ä¼ÒÀÔ´Ï´Ù. º´¿ø ½ÃÀåÀÇ ¾ÐµµÀû ÀÎ Á¸Àç°¨Àº ´ëºÎºÐÀÇ Á¤Çü¿Ü°ú¼ö¼úÀÌ º´¿ø¿¡¼­ ÀÌ·ç¾îÁö±â ¶§¹®ÀÔ´Ï´Ù.

¿ëµµº° Àü¸Á

¿ëµµº°·Î´Â Á¤Çü¿Ü°ú ÅëÁõ °ü¸®, ¿Ü»ó º¹±¸, ¿¬°ñ ¹× ÈûÁÙ º¹±¸, °üÀý Àç°Ç, ±âŸ·Î ³ª´¹´Ï´Ù. ¿¬°ñ ¹× ÈûÁÙ º¹±¸ ºÐ¾ß´Â 2022³â ½ÃÀå ¼ºÀå·üÀÌ °¡Àå ³ôÀº °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ³ëÀΠȯÀÚ Áõ°¡, ¿Ü»ó ȯÀÚ Áõ°¡, ½ºÆ÷Ã÷ ÀÇÇп¡ ´ëÇÑ Àû¿ë µî ¿©·¯ °¡Áö º¯¼ö°¡ ÀÌ ºÎ¹®ÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ¿¬°ñÀÇ ÀÚ¿¬ Ä¡À¯ ´É·ÂÀº ³·½À´Ï´Ù. ¿¬°ñ º´º¯À̳ª ÅëÁõÀ» µ¿¹ÝÇÑ ¿¬°ñ·Î ÀÎÇØ °üÀý ±â´É Àå¾Ö(¹«¸­, ¹ß¸ñ, °í°üÀý, ÆÈ²ÞÄ¡ µî)°¡ ÀÖ´Â »ç¶÷Àº ¼ö¼úÀÌ ÇÊ¿äÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¬°ñ ¼ö¼úÀÌ ¼º°øÇÏ¸é ºÒÆíÇÔÀ» ÁÙÀÌ°í ±â´ÉÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

Á¦Ç° Àü¸Á

Á¦Ç°Àº µ¿Á¾ ÀÌ½ÄÆí, ÇÕ¼º ¿¬°ñ, ¼¼Æ÷ ¿¬°ñ, ºñ½ºÄÚ½º º¸ÃæÁ¦·Î ºÐ·ùµÇ¸ç, ºñ½ºÄÚ½º º¸ÃæÁ¦ ºÎ¹®Àº 2022³â ½ÃÀå¿¡¼­ °¡Àå ³ôÀº ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹«¸­ °ñ°üÀý¿° ȯÀÚ Áõ°¡¿Í ¹«¸­ ÅëÁõÀº ÀÌ ºÎ¹®ÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¹«¸­ °ñ°üÀý¿°Àº ºñ¸¸, ¿Ü»ó, °úµµÇÑ ¿îµ¿, À¯ÀüÀû °¨¼ö¼º, ³ëÈ­¿Í °°Àº ¿äÀÎÀ¸·Î ÀÎÇØ ¾ÇÈ­µÇ±â ¶§¹®¿¡ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô½À´Ï´Ù.

µ¿Á¾ À̽ÄÀÇ Àü¸Á

µ¿Á¾ ÀÌ½ÄÆíÀº ¾ç¸· Á¦Ç°°ú ±âŸ·Î ºÐ·ùµË´Ï´Ù. ±âŸ ºÎ¹®Àº 2022³â ½ÃÀå¿¡¼­ Å« ¸ÅÃâ Á¡À¯À²À» ±â·ÏÇß½À´Ï´Ù. ±âŸ ºÎ¹®¿¡´Â °ñÀÌ½ÄÆí, ÈûÁÙ ÀÌ½ÄÆí, ¿¬°ñ ÀÌ½ÄÆí, ¹Ý¿ù»ó ¿¬°ñÆÇ ÀÌ½ÄÆí, ÇǺΠÀÌ½ÄÆí, ¿¬ºÎÁ¶Á÷ ÀÌ½ÄÆí, Żȸ°ñ ¸ÅÆ®¸¯½º(DBM) µîÀÌ Æ÷ÇԵ˴ϴÙ. ȯÀÚÀÇ »óÅÂ, ¼ö¼ú ³»¿ë ¹× ¿Ü°úÀÇ»çÀÇ Àç·®¿¡ µû¶ó ƯÁ¤ À¯ÇüÀÇ µ¿Á¾ ÀÌ½ÄÆíÀÌ Ã¤ÅÃµÉ ¼öµµ ÀÖ½À´Ï´Ù.

Áö¿ªº° Àü¸Á

Áö¿ªº°·Î º¸¸é ½ÃÀåÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«·Î ºÐ¼®µË´Ï´Ù. ºÏ¹Ì ºÎ¹®Àº 2022³â ½ÃÀå¿¡¼­ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» ±â·ÏÇß½À´Ï´Ù. ÀÌ Áö¿ª ½ÃÀåÀÇ ¿ìÀ§´Â Áß¿äÇÑ ÁøÀÔÀÚÀÇ Á¸Àç, ij³ª´Ù¿Í ¹Ì±¹ÀÇ ±â¼úÀûÀ¸·Î °¡Àå Áøº¸µÈ ÀÇ·á ½Ã½ºÅÛ, ³ëÀÎ Àα¸ Áõ°¡ µî ¸î °¡Áö ¿ä¼Ò¿Í °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ij³ª´Ù Åë°èûÀÇ ¼öÄ¡¿¡ µû¸£¸é 2022³â 7¿ù ÇöÀç ij³ª´ÙÀÇ 65¼¼ ÀÌ»ó Àα¸´Â 730¸¸ ¸íÀ̸ç, Æò±Õ ¿¬·ÉÀº 41¼¼ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀå ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦2Àå ½ÃÀåÀÇ °³¿ä

Á¦3Àå ½ÃÀå °³¿ä

Á¦4Àå ¼¼°èÀÇ Á¤Çü¿Ü°ú Àç»ýÀÇ·á Á¦Ç° ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

Á¦5Àå ¼¼°èÀÇ Á¤Çü¿Ü°ú Àç»ýÀÇ·á Á¦Ç° ½ÃÀå : ¿ëµµº°

Á¦6Àå ¼¼°èÀÇ Á¤Çü¿Ü°ú Àç»ýÀÇ·á Á¦Ç° ½ÃÀå : Á¦Ç°º°

Á¦7Àå ¼¼°èÀÇ Á¤Çü¿Ü°ú Àç»ýÀÇ·á Á¦Ç° ½ÃÀå : Áö¿ªº°

Á¦8Àå ±â¾÷ °³¿ä

Á¦9Àå Á¤Çü¿Ü°ú¿ë Àç»ýÀÇ·á Á¦Ç° ½ÃÀåÀÇ È¹µæ Çʼö»çÇ×

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Orthopedic Regenerative Surgical Products Market size is expected to reach $5.4 billion by 2030, rising at a market growth of 4.2% CAGR during the forecast period.

Over the past ten years, interest in orthobiologics, which includes amniotic materials, has grown for the treatment of numerous orthopedic disorders, including osteoarthritis. Consequently, the Amniotic Products segment will capture around 3/4th share in the market by 2030. One subtype of orthobiologics that is being researched as a potential therapeutic option involves enhancing joint inflammation and healing with amniotic-derived materials, such as amniotic membranes as well as amniotic fluid products. In recent years, research into amniotic-derived products for orthopedic tissue regeneration, including ligament and tendon healing, treatment of plantar fasciitis, spinal pathologies, cartilage restoration, and osteoarthritis, has increased. Some of the factors impacting the market are the increasing number of orthopedic conditions, rising R&D investments propelling technological improvements, and low reimbursement rates and onerous regulatory requirements.

Orthopedic regenerative surgical solutions are in high demand due to the rising prevalence of musculoskeletal problems and orthopedic injuries like tendinitis (tendonitis), osteoarthritis, and ligament injuries. One of the injuries widely researched in orthopedic treatment and research is a ligament damage known as an anterior cruciate ligament (ACL) injury. In professional football, these accidents are becoming more frequent. Osteoarthritis (OA) is the most prevalent type of arthritis, while there are thought to be more than 100 different forms. The high frequency of arthritis results in significant personal and societal consequences. Furthermore, Products for orthopedic regenerative surgery are anticipated to profit from technological developments by expanding R&D research and utilizing cutting-edge technologies, including viscosupplements, stem cells, and platelet rich plasma (PRP) therapies. In a study published in the International Journal of Complementary and Alternative Medicine, many survey participants supported using regenerative medicine therapies to address musculoskeletal problems. Therefore, the market will grow due to the increase in the number of orthopedic conditions and the technological developments in regenerative medicines.

However, the Centers for Medicare and Medicaid Services (CMS) establish payment schedules and decide which operations and technologies are worth paying for. Recent CMS reimbursement rate cuts could cost hospitals, and surgery centers billions of dollars. The Comprehensive Care for Joint Replacement model is a new value-based payment scheme that CMS introduced in 2016. Healthcare professionals and patients may be reluctant to use these therapies if payment policies for orthopedic regenerative surgical products are insufficient or unclear. Financial obstacles resulting from reimbursement issues may restrict patients' access to these treatments. Thus, the difficulties in the provision and accessibility of reimbursement policies may hamper the market's growth.

Additionally, as a result of decreased sales and demand, interruptions in clinical research, and the postponement of elective treatments, the COVID-19 pandemic had a negative influence on the market. As a result of disruptions in the supply chain, travel restrictions, closures of businesses, illness or quarantine among employees, and policies for social distance, organizations experienced additional operational obstacles. To reduce the risk of cross-contamination and increase the capacity to treat patients infected with the coronavirus, a significant number of medical facilities around the world suspended or postponed scheduled elective surgical procedures. However, in the coming years, the market is expected to grow owing to the resumption of elective operations.

End-use Outlook

Based on end-use, the market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment procured the highest revenue share in the market in 2022. The main source of revenue for the healthcare business and a crucial component that fosters innovation and research are hospitals. The overwhelming presence of the hospital market can be traced to the fact that most orthopedic procedures occur in hospitals.

Application Outlook

By application, the market is divided into orthopedic pain management, trauma repair, cartilage & tendon repair, joint reconstruction, and others. The cartilage and tendon repair segment garnered a remarkable growth rate in the market in 2022. Numerous variables, including the expanding number of geriatric patients, trauma cases, and sports medical applications, are responsible for the expansion of the segment. The ability of cartilage to heal itself is low. Due to chondral lesions or painful cartilage, surgery may be required for people with joint dysfunction (e.g., knee, ankle, hip, or elbow). Successful cartilage surgery lessens discomfort and improves functionality.

Product Outlook

Based on product, the market is characterized into allografts, synthetic, cell-based, and viscosupplements. The viscosupplements segment garnered the highest revenue share in the market in 2022. The increase in osteoarthritis cases and knee pain has been attributed to the growth of the segment. Knee osteoarthritis is exacerbated by factors including obesity, external injuries, excessive activity, hereditary susceptibility, and aging, which is why there is such a high demand for the product.

Allografts Outlook

The allografts segment is further classified into amniotic products and others. The others segment recorded a significant revenue share in the market in 2022. The others segment can include bone allografts, tendon allografts, cartilage allografts, meniscus allografts, skin allografts, soft tissue allografts, and demineralized bone matrix (DBM). Depending on the patient's condition, the surgery, and the surgeon's discretion, a particular allograft type may be employed.

Regional Outlook

Region wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded the largest revenue share in the market in 2022. The dominance of this regional market can be linked to several elements, including the existence of important players, technologically cutting-edge healthcare systems in Canada and the United States, and the rising senior population. For example, as of July 2022, Canada had 7.3 million people who are 65 or older, with a median age of 41 years, according to figures from Statistics Canada.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include MiMedx Group, Inc., Vericel Corporation, Baxter International, Inc., Zimmer Biomet Holdings, Inc., Stryker Corporation, Smith & Nephew, Arthrex, Inc., BioTissue Holdings, Inc., VSY Biotechnology GmbH and Aptissen S.A.

Scope of the Study

Market Segments covered in the Report:

By End-use

By Application

By Product

By Geography

Companies Profiled

Unique Offerings from KBV Research

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Global Orthopedic Regenerative Surgical Products Market by End-use

Chapter 5. Global Orthopedic Regenerative Surgical Products Market by Application

Chapter 6. Global Orthopedic Regenerative Surgical Products Market by Product

Chapter 7. Global Orthopedic Regenerative Surgical Products Market by Region

Chapter 8. Company Profiles

Chapter 9. Winning Imperative for Orthopedic Regenerative Surgical Products Market

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â